Literature DB >> 15140928

Noradrenergic inhibition of midbrain dopamine neurons.

Carlos A Paladini1, John T Williams.   

Abstract

Receptors that couple to phosphoinositide hydrolysis, which include metabotropic glutamate receptors (mGluRs) and muscarinic receptors, are known to either activate or inhibit the activity of dopamine cells depending on the pattern of receptor activation. Transient activation of alpha1 adrenoceptors with norepinephrine (NE) resulted in an outward current in midbrain dopamine neurons recorded in brain slices. The NE-mediated outward current was induced by activation of a potassium conductance through release of calcium from intracellular stores. Unlike the mGluR-mediated outward current, the outward current induced by alpha1 adrenoceptors often consisted of multiple peaks. Activation of alpha1 adrenoceptors also induced a wave of calcium release that spread through the soma and proximal dendrites without a decline in amplitude or rate of propagation and therefore differed qualitatively from that induced by mGluRs. Finally, the alpha1 adrenoceptor-activated outward current was more sensitive to the calcium store-depleting agents ryanodine and caffeine. Thus, although both alpha1 adrenoceptors and mGluRs mobilize calcium from intracellular stores, the mechanisms and pools of calcium differ. The results suggest that noradrenergic innervation of dopamine cells can directly inhibit the activity of dopamine cells. Psychostimulants, such as amphetamine, will therefore have a direct effect on the firing pattern of dopamine neurons through a combination of actions on dopamine and alpha1 adrenoceptor activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140928      PMCID: PMC6729397          DOI: 10.1523/JNEUROSCI.5735-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  CRF facilitates calcium release from intracellular stores in midbrain dopamine neurons.

Authors:  Arthur C Riegel; John T Williams
Journal:  Neuron       Date:  2008-02-28       Impact factor: 17.173

2.  Comparison of the VTA and LC response to methylphenidate: a concomitant behavioral and neuronal study of adolescent male rats.

Authors:  Tahseen J Karim; Cruz Reyes-Vazquez; Nachum Dafny
Journal:  J Neurophysiol       Date:  2017-06-14       Impact factor: 2.714

Review 3.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

4.  Alpha-1 adrenoreceptors modulate GABA release onto ventral tegmental area dopamine neurons.

Authors:  Maria C Velásquez-Martínez; Rafael Vázquez-Torres; Legier V Rojas; Priscila Sanabria; Carlos A Jiménez-Rivera
Journal:  Neuropharmacology       Date:  2014-09-28       Impact factor: 5.250

Review 5.  Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms.

Authors:  H Morikawa; C A Paladini
Journal:  Neuroscience       Date:  2011-08-16       Impact factor: 3.590

6.  Neuropsychopharmacological regulation of performance on creativity-related tasks.

Authors:  David Q Beversdorf
Journal:  Curr Opin Behav Sci       Date:  2018-09-27

7.  Separating analgesia from reward within the ventral tegmental area.

Authors:  E Schifirneţ; S E Bowen; G S Borszcz
Journal:  Neuroscience       Date:  2014-01-13       Impact factor: 3.590

8.  Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers.

Authors:  Carlos A Mejías-Aponte; Candice Drouin; Gary Aston-Jones
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

Review 9.  Norepinephrine and stimulant addiction.

Authors:  Mehmet Sofuoglu; R Andrew Sewell
Journal:  Addict Biol       Date:  2008-09-22       Impact factor: 4.280

Review 10.  Heterogeneity of dopamine neuron activity across traits and states.

Authors:  M Marinelli; J E McCutcheon
Journal:  Neuroscience       Date:  2014-07-30       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.